← All trials
NCT06429657
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2024
- Primary completion
- Jan 1, 2027
- Completion date
- Jun 30, 2027
- First posted
- May 28, 2024
- Last posted
- Nov 4, 2024
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Henry M. Jackson Foundation for the Advancement of Military MedicineLead sponsor
- United States ArmyCollaborator
- Uniformed Services University of the Health SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.